WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007078990) MODIFIED LYSINE-MIMETIC COMPOUNDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/078990    International Application No.:    PCT/US2006/048790
Publication Date: 12.07.2007 International Filing Date: 21.12.2006
IPC:
C07C 233/81 (2006.01), C07D 207/16 (2006.01), C07D 207/50 (2006.01), C07D 233/02 (2006.01), A61K 31/4015 (2006.01), A61K 31/4166 (2006.01), A61P 9/00 (2006.01)
Applicants: ZEALAND PHARMA A/S [DK/DK]; Smedeland 26B, DK-2600 Glostrup (DK) (For All Designated States Except US).
WYETH [US/US]; Five Giralda Farms, Madison, NJ 07940 (US) (For All Designated States Except US).
LARSEN, Bjarne, Due [DK/DK]; (DK) (For US Only).
PETERSEN, Jorgen, Soberg [DK/DK]; (DK) (For US Only).
HAUGAN, Ketil, Jorgen [NO/DK]; (DK) (For US Only).
BUTERA, John, A. [US/US]; (US) (For US Only).
HENNAN, James, K. [CA/US]; (US) (For US Only).
KERNS, Edward, H. [US/US]; (US) (For US Only).
PIATNITSKI, Evgueni, Lvovich [RU/US]; (US) (For US Only)
Inventors: LARSEN, Bjarne, Due; (DK).
PETERSEN, Jorgen, Soberg; (DK).
HAUGAN, Ketil, Jorgen; (DK).
BUTERA, John, A.; (US).
HENNAN, James, K.; (US).
KERNS, Edward, H.; (US).
PIATNITSKI, Evgueni, Lvovich; (US)
Agent: MCDONELL, Leslie, A., Esq.; Finnegan, Henderson, Farabow, Garrett, & Dunner LL, P., 901 New York Avenue, NW, Washington, D.C. 20001-4413 (US)
Priority Data:
60/753,628 23.12.2005 US
Title (EN) MODIFIED LYSINE-MIMETIC COMPOUNDS
(FR) COMPOSÉS MODIFIÉS MIMÉTIQUES DE LA LYSINE
Abstract: front page image
(EN)Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
(FR)L'invention concerne des composés mimétiques de la lysine ayant une activité pharmacologique utile, par exemple une activité antiarythmique, ainsi que des propriétés de biodisponibilité souhaitables.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)